Optogenetics approach could restore visual function in retinitis pigmentosa
Companies are exploring light-sensitive proteins method in patients with advanced disease.
Should endocyclophotocoagulation be considered part of MIGS? Mr Ratnarajan delves in
Mr Gokulan Ratnarajan recaps his 2022 ESCRS presentation: "A Real World Comparison Of iStent Combined With Phacoemulsification And Endocyclophotocoagulation (Ice2) With Preserflo And Xen-45 Implants In The UK; Short- And Long-Term Outcomes."
Investigating better indications and outcomes in laser refractive surgery
Prof. Martin Dirisamer speaks with Editor Caroline Richards about his ESCRS instructional course, "Mastering laser refractive surgery: Indications and outcomes."
Investigating the effects of canaloplasty on corneal epithelium
Dr David Lubeck talks with Caroline Richards of Ophthalmology Times Europe about his ESCRS presentations, touching on surgical effects on corneal epithelium and the iTrack Global Registry for glaucoma.
Avoiding errors when converting to DMEK
Prof. Martin Dirisamer discusses his instructional course on common mistakes when performing DMEK and how to avoid them at ESCRS.
EDOF lens tech is evolving to help more patients with intermediate vision
Assistant Prof. of ophthalmology Basak Bostanci discusses her ESCRS presentation, “Extended Range Of Vision In Unusual Cases” and how EDOF lens technology is evolving to include a wider pool of candidates.
Fixoflex ring: Prof. Pallikaris describes how to utilise the device during IOL implantation
Prof. Ioannis Pallikaris discusses his 2022 ESCRS presentation: "Peripheral Capsule Reconstruction And IOL Centration With The Fixoflex Ring".
Top ophthalmologists anticipate ESCRS sessions
Members of the Ophthalmology Times Europe Editorial Advisory Board offer comments on the symposia they are most excited to attend at the 2022 ESCRS Congress in Milan, Italy.
Congress of the ESCRS reaches milestone age
Taking place from 16–20 September 2022, and following the success of last year’s congress, the 40th ESCRS will again be a face-to-face event but supported by a virtual conferencing platform that will allow the sessions to also be streamed.
Interim global survey analysis reveals opportunities to improve patient outcomes
Data highlights need for educational materials and training resources in DMO and DR.
Positive interim data in Phase 2 BEHOLD trial investigating UBX1325 in DMO patients
12-week interim results of BEHOLD, a proof-of-concept Phase 2a study investigating the candidate UBX1325, provides a positive outlook for a novel senolytic approach for previously-treated patients with diabetic macular oedema.
Fluid monitor utilises AI to identify, localise and quantify retinal fluid
Eyecare specialists benefit from being able to monitor their patients long term for optimised and personalised treatment regimens, as well as having access to a more efficient workflow and one which enables them to see more patients.
Multicentre Phase 3 clinical trial using AI in nAMD identifies, measures fluid volumes in real time
According to Dr Gregor S. Reiter, the results from the multicentre Phase 3 clinical trial demonstrated that fluid volumes in patients with nAMD can be precisely identified, localised and measured in real-time using artificial intelligence.
How, when and why to use AI in the clinical management of nAMD
Automated quantitative fluid analyses are enabling personalised treatments, better patient outcomes.
The need for precision management in glaucoma moves field forward
Genotyping and artificial intelligence are together starting to predict the progression of glaucoma in individual patients, sparing them from suboptimal treatments and side effects. Recent research efforts are exploring modifiable risk factors such as caffeine consumption.
Simulated operation practice, artificial intelligence diagnostics dominate discussion on final day of ESCRS 2021
Ophthalmologists gather to discuss artificial intelligence and the issue of false negatives, practice for surgeons and Best of the Best at the European Society of Cataract and Refractive Surgeons congress.
Patient-centric healthcare, combined surgeries and cost-effectiveness considered at ESCRS
Talk of lens selection and patient satisfaction dominated discussion during the Advanced IOLs Symposium; cost vs. benefit analysis emerges as a theme throughout the congress.
A melting pot of curious minds congregate in-person and virtually at this year’s ESCRS
Opportunities lie ahead at the 39th ‘hybrid’ ESCRS
The 39th Congress of the European Society for Cataract and Refractive Surgery (ESCRS) will meet at RAI Congress Centre in Amsterdam, the Netherlands, from 8–11 October 2021. The Congress will also be held virtually, making the chance to participate in some capacity a reality for all.
Ophthalmology: A pioneer in the field of artificial intelligence
Ophthalmology, with its heavy reliance on imaging, is an innovator in the field of artificial intelligence in medicine.
Precision management to revolutionise glaucoma diagnosis and treatment
Artificial intelligence and genetic testing are expected to facilitate choosing the best treatment for each unique glaucoma patient within the next decade. This will not only lead to the best outcomes for individuals but will also spare them the costs and side effects of suboptimal treatments.
How dry eye disease can become a complex vicious cycle
The vicious cycle theory is a new way of understanding dry eye disease and may help improve prevention and treatment strategies.
COVID-19: How one ophthalmologist is dealing with non-urgent cases
The ophthalmic implications of COVID-19: What we know so far
Emerging data on conjunctivitis cases in COVID-19 patients necessitate high levels of caution and a meticulous approach during the pandemic.
Being the ‘boss’ of the graft
A meeting of minds at the 36th Congress of ESCRS
Opportunities and challenges in the world of ophthalmology in 2018
As another year comes to an end, five members of Ophthalmology Times Europe’s Editorial Advisory Board reflect and share their perspectives on the exciting opportunities that lie ahead for ophthalmologists in 2018, whilst also considering the potential challenges.
Multisensory art the focus of exhibition at London's Science Museum
A three-day exhibition that shows how people with visual impairments can appreciate a wide range of art forms was unveiled at the Science Museum on 8th August 2017.
Studying aqueous humour outflow with aqueous angiography
A pioneering dye-based technique that enables aqueous humour outflow to be studied has the potential to improve glaucoma angle-based procedures and surgery outcomes.
Global eye care hope soars with airborne teaching hospital
An aircraft that houses an ophthalmic teaching hospital, containing an on-board operating theatre, training and broadcasting facilities, and treatment rooms, recently visited London Stansted Airport in the UK.
2 Commerce Drive Cranbury, NJ 08512